T
imely HIV testing persists as a major public health challenge in the United States. Of the more than 1 million persons in the United States who are infected with HIV, 300 000 are unaware of their HIV seropositivity (1) . These persons tend to receive HIV testing late in the course of the disease (2) and unknowingly infect others, which accounts for most new HIV infections (3) .
Over the past decade, Centers for Disease Control and Prevention (CDC) recommendations have evolved from risk-assessment-based testing to "routine voluntary counseling and testing" for all adults in all health care settings. Despite the revised guidelines, low HIV screening rates persist (4) . According to providers, barriers to screening include the written informed consent process, time constraints of the patient encounter, and discomfort with discussing HIV risk behavior (5, 6) . Patient-level barriers include low self-perceived risk and fear of stigmatization (7) . Because of such barriers, missed opportunities for earlier diagnosis of HIV infection are common (8, 9) .
In September 2006, the CDC recommended a new paradigm for HIV testing: opt-out HIV screening for all patients in all health care settings (1) . In the CDC's version of opt-out testing, the provider notifies the patient that HIV testing will be performed and offers the patient the opportunity to ask questions and to decline testing. In this paradigm, separate written consent and prevention counseling are not required for HIV testing. The target population for screening is all patients age 13 to 64 years who present to emergency departments, primary care, and other health care settings. Expanding on the 2001 recommendations for HIV testing of pregnant women (10), the 2006 recommendations specifically advocate opt-out screening, stipulating that HIV testing be included in the panel of routine prenatal screening tests. Although not without controversy (11) (12) (13) (14) , the shift to opt-out screening is intended to expand HIV testing by destigmatizing the testing process and ameliorating provider-and patient-level barriers.
Although these recommendations represent an opportunity to increase HIV screening, the potential for state laws to enable or obstruct implementation of the recommendations is not well understood. Existing literature on laws that relate to HIV testing provides a limited summary of the types of state laws that may conflict with routine HIV testing (15, 16) or focuses on federal law that may have ramifications for opt-out HIV testing (17) . No stateby-state analysis of whether implementation of the CDC recommendations is consistent with state statutes has been published. Furthermore, the literature uses an inaccurately broad understanding of opt-out testing rather than the specific CDC recommendations for opt-out HIV screening. This has led to interpretive errors and the inaccurate generalization that state laws are incompatible with implementation of the recommendations.
To offer policymakers and providers a comprehensive analysis, we performed a state-by-state review of all statutes pertaining to HIV testing and systematically assessed the compatibility of these laws with the new recommendations. We developed criteria for classifying state statutory frameworks as consistent, neutral, or inconsistent with the new recommendations and evaluated the implications for implementation of the recommendations in these various legal contexts. We examined HIV testing statutes during the 2 years after release of the 2006 CDC recommendations to capture new laws and legislative trends.
METHODS
The 2006 CDC "Revised Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women in Health-care Settings" (1) contain substantive changes to 3 components of the standard HIV testing process: consent for testing, pre-and posttest counseling, and method of offering screening to adults and pregnant women. To enable a detailed assessment of state law consistency with the CDC recommendations, we first recorded the key features of the recommendations within each of these components, including the specific, CDC-provided definitions of such terms as "opt-out screening," "informed consent," and "HIV prevention counseling." We then systematically identified all state statutes pertaining to HIV testing in the 50 states and Washington, DC, by using the legal search engines Lexis-Nexis and Westlaw (see Appendix, available at www.annals.org, for search strategy). We performed a systematic survey of laws at 6, 12, and 24 months after the September 2006 release of the recommendations.
After the survey, we reviewed the statutes for their relevance to each of the 3 testing components addressed by the CDC recommendations. If we deemed a statute relevant, we assessed its language to determine the extent to which it permitted, obstructed, or was silent on the implementation of the testing component recommendation in question. We classified laws that permitted or promoted implementation as consistent with the testing component recommendation, laws that were barriers to implementation as inconsistent, and laws that were silent about or neither conformed to nor conflicted with the testing component recommendation as neutral.
To summarize a state's entire statutory framework, we developed criteria for classifying it as consistent, neutral, or inconsistent with the CDC recommendations. We classified a state statutory framework as consistent if any of its laws were consistent with either the consent, counseling, or prenatal provisions and it had no laws that were inconsistent with any of these provisions. We classified a statutory framework in which all laws were neutral on each of the 3 CDC provisions as neutral and a framework with 1 or more laws that were inconsistent with 1 or more of the 3 provisions as inconsistent.
RESULTS

Adult Consent for Testing
According to the recommendations (1), a patient should be provided "oral or written information about the test and the opportunity to ask questions and to decline testing, and with such notification, consent for HIV screening should be incorporated into the patient's general informed consent for medical care." The statutory requirements for obtaining consent and the degree to which statutes were consistent with the consent provision of the recommendations varied considerably ( Table 1 ) (18 -53) .
Pre-and Posttest Counseling
The recommendations state that personalized and interactive HIV risk reduction counseling should not be required for any patients at the time of testing; patients at high risk should instead be offered such counseling through referral. The recommendations do require the provision of pretest information, a step considered a key component of, or sometimes entirely constitutive of, "pretest counseling" by some state laws. The CDC defines "pretest information" as "oral or written information that includes an explanation of HIV infection and the meanings of positive and negative test results." The recommendations state that negative test results may be conveyed without direct personal contact between patient and provider and that posttest counseling is not required. For positive results, the recommendations require communication of the result through personal contact along with efforts to ensure linkage to venues that provide HIV care and counseling. Table 1 presents the statutory requirements for counseling.
Method of Offering Screening to Adults and Pregnant Women
The CDC defines an "opt-out screening" process as informing a patient orally or in writing that HIV testing will be performed unless they decline. Opt-out screening is intended for all patients, including pregnant women during prenatal care and at labor and delivery, who do not have a documented negative test result. State consistency with these recommendations varied (Table 2) (54 -72).
Overall Consistency of Each State's Statutory Framework
The Figure depicts the consistency of each state's statutory framework. In the 16 states that were inconsistent, implementation of 1 or more of the 3 new provisions of the recommendations would not be possible without amendment of existing laws. Laws in the 20 states that were neutral neither promoted nor obstructed the 3 provisions. Among the 15 states that were consistent, 9 had laws that were in agreement with all 3 of the provisions and 6 had laws that were in agreement with 1 or 2 of the provisions and were neutral on the others.
In the 2 years since the release of the CDC recommendations, 9 states had passed laws that moved them from the 
DISCUSSION
In the national discussion about how best to perform routine HIV screening in accordance with CDC recommendations, state law is often identified as a barrier to implementation. In this systematic review and analysis, we found that 34 states and Washington, DC, have statutory frameworks that are consistent with or neutral to the CDC recommendations. From a state statutory perspective, implementation of the recommendations is permissible in these states. Sixteen states have statutory frameworks that are inconsistent with the recommendations and would need to amend legislation to fully implement them. The movement of 9 states from the inconsistent to consistent category indicates a trend toward enabling HIV screening in the spirit of the CDC recommendations.
We performed a comprehensive, state-specific survey of statutes pertaining to HIV testing and analyzed the consistency of each law with new and corresponding provisions of the CDC recommendations. To our knowledge, our findings are the first to provide policymakers and providers with information about their own legal context and to clarify the degree to which state law enables or obstructs routine HIV screening. The only other published literature on HIV testing statutes provides a general overview of how certain types of laws may impede routine HIV screening (15) or an appraisal limited to whether states require written informed consent (16) . Public health students maintain a compendium of state HIV testing laws online (73), Apart from statutory consistency, several other issues must be considered before implementing the CDC recommendations. State regulations, which are adopted by state agencies to interpret, implement, and enforce state laws (75) , may also govern the HIV testing process; for example, by requiring written consent even when not called for by law. An analysis of state regulations is beyond the scope of our research, but public health officials and providers should also review state regulations before implementing the recommendations. Similarly, they should examine judicial decisions about HIV testing.
Any opt-out screening process must adhere to the highest standards of medical ethics and human rights protections (17) . Citing concerns about patient autonomy during opt-out screening and the effect of stigma and discrimination on patients receiving a diagnosis of HIV without adequate counseling, some human rights scholars and civil rights groups have expressed reservations about the new CDC recommendations (11, 13, 14) . They argue that the use of "general consent," in which a patient authorizes a medical intervention without an explicit discussion about the risks and benefits of the intervention, is problematic because of HIV-related stigma (14) . Moreover, those who test positive must be offered effective linkage to care, which requires that care programs be adequately funded (17) .
The CDC recommendations, however, do address many of the concerns raised by critics, and in some cases require even more protection for patients than state laws currently require. For example, the CDC does not endorse a typically understood opt-out and general consent process, as is done with other routine screening tests. Instead, although the recommendations still use the term "opt-out screening," they actually call on providers to offer pretest process and about the importance of establishing referral mechanisms with HIV prevention and care providers. Each of these requirements is difficult to achieve and may require coordinated efforts from public health departments, provider groups, and other stakeholders. The first published data on an opt-out HIV screening program based in an emergency department (76) revealed that half of patients with positive test results did not establish care and were lost to follow-up, which illustrates the challenge. This screening program has since introduced a policy of having an infectious diseases physician see patients briefly while they are in the emergency department and arrange a clinic appointment within 24 hours. For settings without immediate access to infectious disease specialists, establishing formal collaborations with community-based HIV/AIDS organizations and clinical HIV/AIDS care providers may be necessary to ensure linkage to care. 
Medicine and Public Issues
Consistency of State Statutes With CDC HIV Testing Recommendations
It is important not to lose sight of patient perspectives on and satisfaction with an opt-out HIV screening process, particularly for vulnerable populations that may have limited access to health care services and are disproportionately at risk for HIV stigma and discrimination (77) . To date, patient acceptability of opt-out HIV screening has been examined only by presentation of hypothetical scenarios through convenience sample surveying of emergency department patients (78). Further research on patient perspectives is needed to tailor the screening process for different populations and to identify unintended consequences.
Finally, we note that the completeness of our review of statutory law depends on the efficacy of our search methodology, as well as the accuracy of the legal search engines we used. It is possible that a few legislative developments were not captured. We sought to mitigate this by using 2 legal search engines and performing a systematic survey of laws at 3 time points.
With more than one-quarter million Americans unaware of their HIV-positive status and 56 000 new HIV infections occurring per year (79) , it is incumbent on our health system to improve HIV screening rates. In addition to unknowingly transmitting the virus, persons unaware of their positive status often already meet the criteria for AIDS by the time they have a positive test result (80, 81), which compromises long-term immune recovery even with appropriate antiretroviral therapy (82, 83) . In a national survey, 65% of respondents supported treating HIV testing like routine screening for any other disease (84) . Multiple analyses (85) (86) (87) indicate that HIV screening according to the CDC recommendations are cost-effective. Misinterpretation of the CDC recommendations and inaccurate generalizations about state statutes should not derail implementation. Although many critics have voiced concern about potential statutory barriers, state statutes that govern HIV testing are in fact increasingly compatible with implementation of the CDC recommendations. 
